248 related articles for article (PubMed ID: 9626568)
1. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
[TBL] [Abstract][Full Text] [Related]
2. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
Hazell LJ; Davies MJ; Stocker R
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
[TBL] [Abstract][Full Text] [Related]
3. Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids.
Carr AC; Decker EA; Park Y; Frei B
Free Radic Biol Med; 2001 Jul; 31(1):62-72. PubMed ID: 11425491
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
5. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
6. Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro.
Yang CY; Gu ZW; Yang M; Lin SN; Garcia-Prats AJ; Rogers LK; Welty SE; Smith CV
J Lipid Res; 1999 Apr; 40(4):686-98. PubMed ID: 10191293
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of tryptophan oxidation in plasma lipoproteins by myeloperoxidase-generated HOCl.
Jerlich A; Hammel M; Nigon F; Chapman MJ; Schaur RJ
Eur J Biochem; 2000 Jul; 267(13):4137-43. PubMed ID: 10866816
[TBL] [Abstract][Full Text] [Related]
8. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.
Hazell LJ; Baernthaler G; Stocker R
Free Radic Biol Med; 2001 Nov; 31(10):1254-62. PubMed ID: 11705704
[TBL] [Abstract][Full Text] [Related]
9. Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation.
Jerlich A; Fritz G; Kharrazi H; Hammel M; Tschabuschnig S; Glatter O; Schaur RJ
Biochim Biophys Acta; 2000 Aug; 1481(1):109-18. PubMed ID: 11004581
[TBL] [Abstract][Full Text] [Related]
10. Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines.
Resch U; Semlitsch M; Hammer A; Susani-Etzerodt H; Walczak H; Sattler W; Malle E
Biochem Biophys Res Commun; 2011 Jul; 410(4):895-900. PubMed ID: 21708126
[TBL] [Abstract][Full Text] [Related]
11. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
[TBL] [Abstract][Full Text] [Related]
12. Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein.
Carr AC; Tijerina T; Frei B
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):491-9. PubMed ID: 10677371
[TBL] [Abstract][Full Text] [Related]
13. Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS.
Jerlich A; Pitt AR; Schaur RJ; Spickett CM
Free Radic Biol Med; 2000 Mar; 28(5):673-82. PubMed ID: 10754262
[TBL] [Abstract][Full Text] [Related]
14. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
[TBL] [Abstract][Full Text] [Related]
15. Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ
Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274
[TBL] [Abstract][Full Text] [Related]
16. Modification of the lipid-protein interaction in human low-density lipoprotein destabilizes ApoB-100 and decreases oxidizability.
Abuja PM; Lohner K; Prassl R
Biochemistry; 1999 Mar; 38(11):3401-8. PubMed ID: 10079085
[TBL] [Abstract][Full Text] [Related]
17. Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.
Kapiotis S; Jirovetz L; Hermann M; Laggner H; Exner M; Esterbauer H; Gmeiner BM
Biochimie; 2006 Jul; 88(7):785-91. PubMed ID: 16488068
[TBL] [Abstract][Full Text] [Related]
18. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
Exner M; Hermann M; Hofbauer R; Hartmann B; Kapiotis S; Gmeiner B
Free Radic Biol Med; 2004 Jul; 37(2):146-55. PubMed ID: 15203186
[TBL] [Abstract][Full Text] [Related]
19. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.
Malle E; Marsche G; Arnhold J; Davies MJ
Biochim Biophys Acta; 2006 Apr; 1761(4):392-415. PubMed ID: 16698314
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation.
Hazell LJ; van den Berg JJ; Stocker R
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):297-304. PubMed ID: 8068018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
